Clinical trial
An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride…
NCT00269776 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00269776 |
|---|---|
| Title | An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder |
| Official title | Screening, Efficacy, and Safety Study Evaluating OROS (Methylphenidate HCl), Ritalin and Placebo in Children With ADHD |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Placebo, OROS (methylphenidate HCl), Ritalin (methylphenidate) |
| Start date | Nov 1, 1998 |
| Completion | Jan 1, 1999 |
| First posted | Dec 26, 2005 |
| Last update posted | Jul 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: